CTRI/2011/06/001819
Completed
Phase 3
Clinical trial to assess the efficacy and safety of fixed dose combination of S-Metoprolol and Telmisartan tablets in hypertension - SMT
Emcure Pharmaceuticals Ltd Pune0 sites200 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Emcure Pharmaceuticals Ltd Pune
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or female patients between 18\-65 years of age, Patients diagnosed with essential hypertension not controlled on monotherapy or newly diagnosed Stage II hypertensives, Patients willing to give written informed consent and willing to comply with study protocol
Exclusion Criteria
- •Patients previously sensitive to any of the ingredients of the fixed dose combination under study or beta blockers or angiotensin receptor blockers, Patients with history of secondary or malignant hypertension, Patients with evidence of any cardiac arrhythmia on ECG, Patients with known significant respiratory/liver/kidney/neurological diseases / uncontrolled diabetes, Pregnant and lactating women or the women of child bearing age who are not practicing the effective means of contraception, Patients who will receive some other drug during the study besides that in the protocol that could alter the pharmacokinetic/ pharmacodynamic profile of the study drug, Patients with known alcohol or drug abuse, Any condition that, in the opinion of the investigator, does not justify the patient?s inclusion in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Clinical trial to assess the efficacy and safety of TNK-TPA in Acute Ischemic StrokeCTRI/2009/091/000251Gennova Biopharmaceuticals Limited Pune50
Completed
Phase 3
A phase III clinical trial study to evaluate the efficacy and safety of Tenecteplase (TNK-TPA) in Acute Ischemic Stroke patientsCTRI/2015/02/005556Gennova Biopharmaceuticals Ltd62
Completed
Phase 3
Efficacy and safety of Fixed Dose Combination of Dexketoprofen Trometamol and Dicyclomine Hydrochloride InjectioCTRI/2010/091/001343Emcure Pharmaceuticals Ltd. Pune200
Not yet recruiting
Not Applicable
Clinical trial to evaluate the safety, efficacy, and economic feasibility of virtual reality-based ‘Emotion to Emotion Therapy’ for post-traumatic stress disorder patientsKCT0007845Wonkwang University Sanbon Hospital72
Recruiting
Not Applicable
Clinical trial to verify the efficacy and safety of improvement of lower extremity muscle function and balance therapy using Electric Orthopedic Exercise Device(WALK WELL™) in hemiplegic stroke patientsKCT0004558Chonbuk National University Hospital30